GSK Plc (GSK)
50.80
+0.90
(+1.79%)
USD |
NYSE |
Jan 14, 16:00
50.74
-0.06
(-0.11%)
After-Hours: 20:00
GSK EPS Diluted (Quarterly): 1.323 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.8065 |
| Biodexa Pharmaceuticals Plc | -- |
| AnaptysBio, Inc. | 0.5208 |
| NuCana Plc | -0.1348 |
| Mereo BioPharma Group Plc | -0.0436 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.891B |
| Revenue (Quarterly) | 11.52B |
| Total Expenses (Quarterly) | 8.810B |
| Enterprise Value | 119.19B |
| Gross Profit Margin (Quarterly) | 73.80% |
| Profit Margin (Quarterly) | 25.08% |
| Earnings Yield | 6.90% |
| Operating Earnings Yield | 9.44% |
| Normalized Earnings Yield | 7.806 |